Huaier Attenuates Renal Injury in Type 2 Diabetic Nephropathy by Ameliorating Mitochondrial Dysfunction and Inhibiting Tubular Epithelial Cell Apoptosis
Journal of Diabetes · 2026-11 · 18 (11)
DOI: 10.1111/1753-0407.70290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 29.10.2026. Verfasst von Yucan Guan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin Province, China. Hauptthemen laut MEDLINE: Apoptosis, Diabetic Nephropathies, Diabetes Mellitus, Type 2, Epithelial Cells. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bethune Program of Jilin University.
Abstract (Originalsprache)
Background
Diabetic nephropathy (DN) is a major microvascular complication of Type 2 diabetes, with renal tubular epithelial cells (RTECs) apoptosis playing a pivotal role in its progression. The aqueous extract of Trametes robiniophila Murr. (Huaier) has shown renoprotective effects, but its specific molecular mechanisms in DN remain to be fully elucidated.
Objective
This study aimed to investigate the therapeutic effects of Huaier aqueous extract on DN and verify whether its anti‐apoptotic mechanism is mediated through the Wnt/β‐catenin pathway using the pathway activator SKL2001.
Methods
In vivo, KKAy Type 2 diabetic mice were treated with Huaier (5 g/kg/day) for 12 weeks to evaluate renal function and histopathology. In vitro, HK‐2 cells were treated with high glucose and palmitate (HG + PA) to induce injury. The Wnt/β‐catenin pathway activator SKL2001 was employed to determine if activating this pathway could abolish the protective effects of Huaier.
Results
Bioinformatics analysis indicates that the regulation of apoptosis is the primary mechanism by which Huaier improves DN. In vivo, Huaier reduced UACR and improved renal histopathology in KKAy mice. Consistently, TUNEL staining and molecular analysis confirmed that Huaier significantly suppressed RTECs apoptosis within the renal tissues. In vitro experiments demonstrated that Huaier significantly inhibited HG + PA‐induced oxidative stress, mitochondrial dysfunction, and RTECs apoptosis. Notably, the administration of SKL2001 effectively reversed these protective effects, leading to increased β‐catenin expression and elevated apoptosis levels despite Huaier treatment.
Conclusion
Huaier aqueous extract mitigates RTECs apoptosis and renal injury in Type 2 diabetic nephropathy by suppressing the Wnt5a/β‐catenin signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin Province, China.
- Clinical Research Department, The Second Hospital of Jilin University, Changchun, Jilin Province, China.
- Center for Pharmacodynamics and Toxicology Evaluation, Jilin Academy of Chinese Medicine Sciences, Changchun, Jilin Province, China.
ORCID-Profile: Yucan Guan, Ping Luo, Ping Nie
Förderung
- Bethune Program of Jilin University
Zitieren
APA
Guan, Y., Bai, X., Wei, X., Ding, T., Luo, P., & Nie, P. (2026). Huaier Attenuates Renal Injury in Type 2 Diabetic Nephropathy by Ameliorating Mitochondrial Dysfunction and Inhibiting Tubular Epithelial Cell Apoptosis. Journal of Diabetes, 18(11). https://doi.org/10.1111/1753-0407.70290
Vancouver
Guan Y, Bai X, Wei X, Ding T, Luo P, Nie P. Huaier Attenuates Renal Injury in Type 2 Diabetic Nephropathy by Ameliorating Mitochondrial Dysfunction and Inhibiting Tubular Epithelial Cell Apoptosis. Journal of Diabetes. 2026;18(11). doi:10.1111/1753-0407.70290
BibTeX
@article{Guan2026,
author = {Guan, Yucan and Bai, Xiaoying and Wei, Xianping and Ding, Tao and Luo, Ping and Nie, Ping},
title = {Huaier Attenuates Renal Injury in Type 2 Diabetic Nephropathy by Ameliorating Mitochondrial Dysfunction and Inhibiting Tubular Epithelial Cell Apoptosis},
journal = {Journal of Diabetes},
year = {2026},
volume = {18},
number = {11},
doi = {10.1111/1753-0407.70290}
}
EUVIMED